The VMD is alerting equine vets to a product defect in a batch of antibiotics that has caused anaphylactic reactions in horses.

Genta-Equine 100mg/mlA recall on the specific batch of Genta-Equine 100mg/ml solution for injection for horses has been announced.

Product defect

In a statement, the VMD said: “The VMD has been made aware of a product defect with one batch of Genta-Equine 100mg/ml solution for injection for horses, an injectable antibiotic containing gentamicin, marketed by Franklin Pharmaceuticals and distributed by Dechra Veterinary Products.

“Serious adverse events resulting in anaphylactic reactions in horses have been reported following use of this product batch. Investigations into the cause of these events are in progress.”

The affected batch is 6054-81A with the expiry date January 2018.

Batch recall

The VMD advises this batch should not be used and a recall to veterinary practice level is in progress. The product is indicated for use in the treatment of infections caused by Gram-negative bacteria sensitive to gentamicin and compatible with the distribution properties of gentamicin.

View your activity >

Leave a Reply

Be the First to Comment!

Notify of
avatar

wpDiscuz

related content

The RSPCA has released examples of some of the funniest incidents of emergency call-outs for RSPCA inspectors in 2016.

Annamaria Nagy and Sue Dyson investigate some of the advances in diagnostic imaging in horses using studies on techniques to discover injuries.

28 mins

The National Equine Forum (NEF) will be celebrating its 25th event on 2 March at the Institution of Mechanical Engineers in London.

4 mins

Suzanne Rogers reports on the results and feedback from a questionnaire with owners at the annual event held in Cumbria.

18 mins

Vets can learn about the investigation and management of disorders of the digital sheath at an equine CPD event in February.

Charity launches a fund-raising appeal to replace a shed to be used for storing veterinary supplies sent to thousands of animals in need across the globe.

3 mins